Large pituitary gland with an expanding lesion in the context of neurofibromatosis 1

BMJ Case Rep. 2017 Oct 25:2017:bcr2017222411. doi: 10.1136/bcr-2017-222411.

Authors

Fady Hannah-Shmouni¹, Andrew P Demidowich², Jennifer Rowell³, Maya Lodish¹, Constantine A Stratakis¹

Affiliations

¹ Section on Endocrinology and Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
² Section on Growth and Obesity, National Institute of Child Health and Human Development, National Institute of Health, Bethesda, Maryland, USA.
³ Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Durham, North Carolina, USA.

No abstract available

Keywords: genetic screening / counselling; medical management; pituitary disorders.

Publication types

Case Reports

MeSH terms

Acromegaly / drug therapy
Acromegaly / etiology*
Adult
Antineoplastic Agents / therapeutic use
Cabergoline
Central Nervous System Cysts / diagnostic imaging
Central Nervous System Cysts / drug therapy
Central Nervous System Cysts / pathology*
Ergolines / therapeutic use
Female
Human Growth Hormone / metabolism
Humans
Magnetic Resonance Imaging
Neurofibromatosis 1 / complications*
Pituitary Gland
Pituitary Neoplasms / diagnostic imaging
Pituitary Neoplasms / drug therapy
Pituitary Neoplasms / pathology*

Substances

Antineoplastic Agents
Ergolines
Human Growth Hormone
Cabergoline

Grants and funding

ZIA HD008920-06/Intramural NIH HHS/United States